WO2003066809A3 - Endonucleases non appariees et leurs procedes d'utilisation - Google Patents

Endonucleases non appariees et leurs procedes d'utilisation Download PDF

Info

Publication number
WO2003066809A3
WO2003066809A3 PCT/US2003/002958 US0302958W WO03066809A3 WO 2003066809 A3 WO2003066809 A3 WO 2003066809A3 US 0302958 W US0302958 W US 0302958W WO 03066809 A3 WO03066809 A3 WO 03066809A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
useful
mismatch endonucleases
restriction endonucleases
endonucleases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/002958
Other languages
English (en)
Other versions
WO2003066809A2 (fr
Inventor
Hal S Padgett
Andrew A Vaewhongs
Fakhrieh S Vojdani
Mark L Smith
John A Lindbo
Wayne P Fitzmaurice
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Large Scale Biology Corp
Original Assignee
Large Scale Biology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/098,155 external-priority patent/US20030157495A1/en
Application filed by Large Scale Biology Corp filed Critical Large Scale Biology Corp
Priority to CA2473187A priority Critical patent/CA2473187C/fr
Priority to AU2003207776A priority patent/AU2003207776B2/en
Priority to JP2003566160A priority patent/JP4395632B2/ja
Priority to DE60314902T priority patent/DE60314902T2/de
Priority to EP03706015A priority patent/EP1565557B1/fr
Publication of WO2003066809A2 publication Critical patent/WO2003066809A2/fr
Anticipated expiration legal-status Critical
Publication of WO2003066809A3 publication Critical patent/WO2003066809A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Disintegrating Or Milling (AREA)

Abstract

L'invention concerne des endonucléases de restriction et leurs applications. Les endonucléases de restriction sont utiles pour trouver des polymorphismes de nucléotide simple. Ces endonucléases de restriction peuvent également être utilisées dans une méthode de redistribution in vitro de variations de séquences entre des séquences polynucléotidiques non identiques.
PCT/US2003/002958 2002-02-01 2003-01-31 Endonucleases non appariees et leurs procedes d'utilisation Ceased WO2003066809A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA2473187A CA2473187C (fr) 2002-02-01 2003-01-31 Endonucleases non appariees et leurs procedes d'utilisation
AU2003207776A AU2003207776B2 (en) 2002-02-01 2003-01-31 Mismatch endonucleases and methods of use
JP2003566160A JP4395632B2 (ja) 2002-02-01 2003-01-31 ミスマッチエンドヌクレアーゼ及び使用方法
DE60314902T DE60314902T2 (de) 2002-02-01 2003-01-31 Fehlpaarungsendonukleasen und verwendungsverfahren
EP03706015A EP1565557B1 (fr) 2002-02-01 2003-01-31 Endonucleases non appariees et leurs procedes d'utilisation

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US35372202P 2002-02-01 2002-02-01
US60/353,722 2002-02-01
US10/098,155 US20030157495A1 (en) 2002-02-01 2002-03-14 Nucleic acid molecules encoding CEL I endonuclease and methods of use thereof
US10/098,155 2002-03-14
US10/211,079 2002-08-01
US10/211,079 US7078211B2 (en) 2002-02-01 2002-08-01 Nucleic acid molecules encoding endonucleases and methods of use thereof

Publications (2)

Publication Number Publication Date
WO2003066809A2 WO2003066809A2 (fr) 2003-08-14
WO2003066809A3 true WO2003066809A3 (fr) 2005-06-30

Family

ID=27739010

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/002958 Ceased WO2003066809A2 (fr) 2002-02-01 2003-01-31 Endonucleases non appariees et leurs procedes d'utilisation

Country Status (8)

Country Link
US (4) US7078211B2 (fr)
EP (1) EP1565557B1 (fr)
JP (1) JP4395632B2 (fr)
AT (1) ATE366807T1 (fr)
AU (1) AU2003207776B2 (fr)
CA (1) CA2473187C (fr)
DE (1) DE60314902T2 (fr)
WO (1) WO2003066809A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436214C (fr) * 2001-02-02 2012-12-04 Large Scale Biology Corporation Procede destine a ameliorer la complementarite d'un heteroduplex
US20110111413A1 (en) * 2001-02-02 2011-05-12 Padgett Hal S Method of optimizing codon usage through dna shuffling
US7838219B2 (en) * 2001-02-02 2010-11-23 Novici Biotech Llc Method of increasing complementarity in a heteroduplex
US7078211B2 (en) * 2002-02-01 2006-07-18 Large Scale Biology Corporation Nucleic acid molecules encoding endonucleases and methods of use thereof
EP1574570A1 (fr) * 2004-03-12 2005-09-14 Universität Regensburg Procédé pour la réduction du nombre de mésappariements nucléotidiques dans des polynucléotides double-brin
ES2292270B1 (es) * 2004-04-14 2009-02-16 Oryzon Genomics, S.A. Procedimiento para detectar selectivamente acidos nucleicos con estructuras atipicas convertibles en muescas.
US20060029612A1 (en) * 2004-04-15 2006-02-09 Large Scale Biology Corporation Prevention and treatment of recurrent respiratory papillomatosis
US20090053261A1 (en) * 2005-09-08 2009-02-26 Lindbo John A Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications
US7729761B2 (en) * 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
CA2575276A1 (fr) * 2004-07-30 2006-02-02 Institut National De La Recherche Agronomique Procede de production d'endonucleases a sensibilite elevee, nouvelles preparations d'endonucleases et leurs utilisations
EP2484768A3 (fr) * 2005-07-18 2012-11-21 Protalix Ltd. Administration mucosale ou enterale de macromolecules biologiquement actives
WO2007101028A2 (fr) * 2006-02-24 2007-09-07 Transgenomic, Inc. Procede de production d'endonucleases recombinantes enzymatiquement actives
US7888475B2 (en) * 2008-09-15 2011-02-15 Padgett Hal S Interferon alpha and interferon kappa fusion protein
WO2011102802A1 (fr) * 2010-02-18 2011-08-25 Agency For Science, Technology And Research Procédé pour réduire les mésappariements dans des molécules d'adn bicaténaires
CN107058059B (zh) 2011-09-26 2020-08-07 基因技术股份公司 高效的小体积核酸合成
US12595500B2 (en) 2011-09-26 2026-04-07 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
WO2014153188A2 (fr) 2013-03-14 2014-09-25 Life Technologies Corporation Synthèse hautement efficace de petits volumes d'acides nucléiques
EP3597764A3 (fr) 2012-02-01 2020-05-06 SGI-DNA, Inc. Matériau et procédés de synthèse de molécules d'acide nucléique à réduction d'erreurs
WO2013152220A2 (fr) 2012-04-04 2013-10-10 Life Technologies Corporation Plate-forme d'assemblage d'effecteur tal, services personnalisés, kits et tests
US20150119260A1 (en) * 2013-10-18 2015-04-30 National Taiwan University Circulating cancer biomarker and its use
WO2016011174A1 (fr) 2014-07-15 2016-01-21 Life Technologies Corporation Compositions et méthodes d'assemblage d'acides nucléiques
US10407676B2 (en) 2014-12-09 2019-09-10 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
US20180195099A1 (en) 2015-07-07 2018-07-12 Thermo Fisher Scientific Geneart Gmbh Enzymatic synthesis of nucleic acid sequences
US20180291413A1 (en) 2015-10-06 2018-10-11 Thermo Fisher Scientific Geneart Gmbh Devices and methods for producing nucleic acids and proteins
WO2017125893A1 (fr) * 2016-01-22 2017-07-27 Vyome Biosciences Pvt. Ltd. Procédé de détection et de traitement de p. acnes et trousse associée
EP3814494B1 (fr) 2018-06-29 2023-11-01 Thermo Fisher Scientific GENEART GmbH Assemblage à haut débit de molécules d'acides nucléiques
GB201905303D0 (en) 2019-04-15 2019-05-29 Thermo Fisher Scient Geneart Gmbh Multiplex assembly of nucleic acid molecules
EP4114972A1 (fr) 2020-03-06 2023-01-11 Life Technologies Corporation Synthèse et assemblage d'acide nucléique à fidélité de séquence élevée
US11667968B2 (en) 2021-05-27 2023-06-06 New England Biolabs, Inc. Fragmentation of DNA
EP4638776A1 (fr) 2022-12-19 2025-10-29 Thermo Fisher Scientific GENEART GmbH Extraction de molécules d'acide nucléique à séquence vérifiée

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783941B2 (en) * 2000-12-06 2004-08-31 Novozymes A/S Method for producing a polynucleotide library in vitro by mismatch repair of heteroduplexes

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US17477A (en) * 1857-06-09 allerton
US48268A (en) * 1865-06-20 Improved process for preparing coffee
US45175A (en) * 1864-11-22 Improved grinding-plate
DE229046T1 (de) * 1985-03-30 1987-12-17 Marc Genf/Geneve Ballivet Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren.
US4994368A (en) * 1987-07-23 1991-02-19 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
US5556750A (en) * 1989-05-12 1996-09-17 Duke University Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems
US5459039A (en) * 1989-05-12 1995-10-17 Duke University Methods for mapping genetic mutations
US5556747A (en) * 1990-07-09 1996-09-17 E. R. Squibb & Sons, Inc. Method for site-directed mutagenesis
DE4112440C1 (fr) 1991-04-16 1992-10-22 Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De
US5795747A (en) * 1991-04-16 1998-08-18 Evotec Biosystems Gmbh Process for manufacturing new biopolymers
AU3919293A (en) 1992-03-27 1993-11-08 University Of Maryland At Baltimore Detection of gene mutations with mismatch repair enzymes
US6165793A (en) * 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
DE69633723T2 (de) 1995-06-07 2006-02-02 Trevigen, Inc. Methode zur detektion von punktmutanten mittels nukleinsäurereperaturenzym und in vitro mutagenese
US6057103A (en) * 1995-07-18 2000-05-02 Diversa Corporation Screening for novel bioactivities
WO1997021837A1 (fr) * 1995-12-15 1997-06-19 Amersham Life Science, Inc. Methodes utilisant des systemes de retablissement de mesappariement pour deceler et extraire des sequences mutantes apparaissant au cours d'une amplification enzymatique
WO1997037011A1 (fr) 1996-04-01 1997-10-09 Setratech S.A.R.L. Recombinaison meiotique in vivo de sequences d'adn partiellement homologues
EP0964929B1 (fr) 1996-06-05 2004-10-20 Fox Chase Cancer Center Endonucleases sensibles au mesappariement et leurs utilisations pour la detection de mutations dans des brins de polynucleotides cibles
US5869245A (en) * 1996-06-05 1999-02-09 Fox Chase Cancer Center Mismatch endonuclease and its use in identifying mutations in targeted polynucleotide strands
FR2772048B1 (fr) 1997-12-04 2001-12-21 Biomethodes Procede de clonage par digestion multiple, vecteurs pour sa mise en oeuvre et ses applications
US6537746B2 (en) * 1997-12-08 2003-03-25 Maxygen, Inc. Method for creating polynucleotide and polypeptide sequences
US6846655B1 (en) * 1998-06-29 2005-01-25 Phylos, Inc. Methods for generating highly diverse libraries
FR2789696A1 (fr) 1999-02-12 2000-08-18 Biomethodes Procede de mutagenese d'un fragment d'acide nucleique par clonage et polymerisation-ligation
FR2793807B1 (fr) 1999-05-20 2003-05-16 Biomethodes Methode d'insertion d'un fragment d'acide nucleique dans un vecteur, ses applications et les kits pour sa mise en oeuvre
DE19953854C2 (de) 1999-11-09 2002-01-17 Max Planck Gesellschaft Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften
US6391557B1 (en) * 2000-02-22 2002-05-21 Fox Chase Cancer Center Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof
AU2001247212B2 (en) 2000-02-22 2005-12-22 Fox Chase Cancer Center Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof
EP1283877A2 (fr) * 2000-05-23 2003-02-19 California Institute Of Technology Recombinaison de genes et mise au point de proteines hybrides
FR2813314B1 (fr) 2000-08-25 2004-05-07 Biomethodes Procede de mutagenese dirigee massive
US20040091886A1 (en) 2000-09-21 2004-05-13 Moore Jeffrey C. Method for generating recombinant polynucleotides
CA2436214C (fr) 2001-02-02 2012-12-04 Large Scale Biology Corporation Procede destine a ameliorer la complementarite d'un heteroduplex
US7078211B2 (en) * 2002-02-01 2006-07-18 Large Scale Biology Corporation Nucleic acid molecules encoding endonucleases and methods of use thereof
DE10248258A1 (de) 2002-10-16 2004-05-06 Biopsytec Analytik Gmbh Mutierte Nukleinsäure einer Cel I-Endonuklease und Verfahren zur Herstellung des rekombinanten vollständigen Cel I-Proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783941B2 (en) * 2000-12-06 2004-08-31 Novozymes A/S Method for producing a polynucleotide library in vitro by mismatch repair of heteroduplexes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
OLEYKOWSKI C.A. ET AL: "Incision At Nucleotide Insertions/Deletions And Base Pair Mismatches By The SP Nuclease Of Spinach", BIOCHEMISTRY, vol. 38, 1999, pages 2200 - 2205, XP002222861 *
OLEYKOWSKI C.A. ET AL: "Mutation Detection Using A Novel Plant Endonuclease", NUCL ACIDS RES, vol. 26, no. 20, 1998, pages 4597 - 4602, XP002943289 *

Also Published As

Publication number Publication date
US20060194288A1 (en) 2006-08-31
AU2003207776B2 (en) 2008-12-11
AU2003207776A1 (en) 2003-09-02
EP1565557B1 (fr) 2007-07-11
JP2005529586A (ja) 2005-10-06
US7078211B2 (en) 2006-07-18
DE60314902D1 (de) 2007-08-23
CA2473187C (fr) 2012-07-31
EP1565557A4 (fr) 2005-11-30
JP4395632B2 (ja) 2010-01-13
EP1565557A2 (fr) 2005-08-24
US20030157682A1 (en) 2003-08-21
WO2003066809A2 (fr) 2003-08-14
DE60314902T2 (de) 2008-04-10
US7273739B2 (en) 2007-09-25
CA2473187A1 (fr) 2003-08-14
US20030148315A1 (en) 2003-08-07
US7056740B2 (en) 2006-06-06
US20080145913A1 (en) 2008-06-19
ATE366807T1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
WO2003066809A3 (fr) Endonucleases non appariees et leurs procedes d'utilisation
WO2005014850A3 (fr) Systemes et procedes d'analyse de sequences d'acides nucleiques
AU2003259285A1 (en) Methods of identifying adipocyte specific genes, the genes identified, and their uses
AU2003299585A1 (en) Water-soluble products and methods of making and using the same
AU2003286492A1 (en) Magnetic substrates, composition and methods of making the same
GB0400584D0 (en) Nucleic acid chacterisation
AU2003224652A1 (en) Methods for forming articles having very small channels therethrough, and such articles, and methods of using such articles
AU2003251312A1 (en) Curable adhesive articles having topographical features therein
AU2003297279A1 (en) Processes for electrocoating and articles made therefrom
WO2004034990A3 (fr) Methodes et compositions a utiliser dans le traitement du cancer
AU2003201880A1 (en) Solvent-soluble block copolyimide composition and process for producing the same
WO2004000102A3 (fr) Procede servant a predire une reponse a une therapie dirigee vers le recepteur du facteur de croissance epidermique
CA2438574A1 (fr) Procede de detection de polymorphisme de nucleotide
WO2004013290A3 (fr) Compositions et procedes applicables a la biologie moleculaire
AU2003214887A1 (en) Compositions and methods for polynucleotide sequence determination
DE60225449D1 (de) Wildlederartiges kunstleder und verfahren zu dessen herstellung
AU2003284847A1 (en) Probiotic additive and the production method thereof
WO2004031352A3 (fr) Variants d'interferons presentant des proprietes ameliorees
AU2003225062A1 (en) Thermostable dna polymerases and methods of making same
WO2005001039A3 (fr) Production de petits arn interferents (arnsi) regulee par les ribozymes et procedes d'utilisation de ceux-ci
AU2003303735A1 (en) Oligomer silasesquioxanes, method for the production thereof, and use of the same
AU2003278286A1 (en) Method for producing acrylic acid from propane, in the presence of molecular oxygen
MY136822A (en) Derivatives of [6, 7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide and their use as inhibitors upon the interaction of cams and leukointegrins
WO2005001042A8 (fr) Cellules precurseurs de muscle lisse
PL1663997T3 (pl) 1H-azolilo-metylo-amidy, sposoby ich wytwarzania i ich zastosowanie jako inhibitorów nitryfikacji

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2473187

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003207776

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003566160

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003706015

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003706015

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2003706015

Country of ref document: EP